Profile of the Week

Professor Jain moved from India to the United States in 1972 after receiving a B. Tech in Chemical Engineering from the Indian Institute of Technology. He then attended the University of Delaware, where he completed a M.S. and Ph.D. in Chemical Engineering. Professor Jain served on the faculty of Columbia University for two years and spent 14 years at Carnegie Mellon University. Since 1991, Professor Jain has been the Andrew Werk Cook Professor of Tumor Biology and the Director of the Edwin L. Steele Laboratory for Tumor Biology at Massachusetts General Hospital. Professor Jain is a renowned world expert in understanding how changes in the microenvironment surrounding tumors effect the immune system, drug delivery, treatment efficacy and patient survival. The new immunotherapy called immune checkpoint inhibitors - a class of drugs that block the checkpoints - has revolutionized cancer therapy for some tumors but are not effective in the most aggressive brain tumor, glioblastoma (GBM).